rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk

Author:

Hall Ignacio Fernando12ORCID,Climent Montserrat1ORCID,Viviani Anselmi Chiara1,Papa Laura1ORCID,Tragante Vinicius3,Lambroia Luca14ORCID,Farina Floriana Maria156ORCID,Kleber Marcus E7,März Winfried789,Biguori Carlo10,Condorelli Gianluigi1211ORCID,Elia Leonardo14ORCID

Affiliation:

1. Humanitas Research Hospital‐IRCCS Rozzano Italy

2. Institute of Genetics and Biomedical Research National Research Council Rozzano Italy

3. Department of Cardiology Division Heart and Lungs University Medical Center Utrecht Utrecht University Utrecht The Netherlands

4. Department of Molecular and Translational Medicine University of Brescia Brescia Italy

5. Institute for Cardiovascular Prevention (IPEK) Ludwig‐Maximillians‐Universität (LMU) München Munich Germany

6. Department of Medical Biotechnology and Translational Medicine University of Milan Milan Italy

7. Vth Department of Medicine Medical Faculty Mannheim Heidelberg University Mannheim Germany

8. SYNLAB Academy SYNLAB Holding Deutschland GmbH Augsburg and Mannheim Germany

9. Clinical Institute of Medical and Chemical Laboratory Diagnostics Medical University Graz Graz Austria

10. Interventional Cardiology Unit Mediterranea Cardiocentro Naples Italy

11. Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

Funder

H2020 Future and Emerging Technologies

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3